top of page

Elise Viox received her B.S. in Biology and B.A. in Human Health from Emory University in 2015. She then completed a postbac at the NIH Vaccine Research Center in the lab of Dr. John Mascola where she evaluated the HIV-1 fusion peptide as a potential immunogen for HIV-1 vaccine design in mouse, guinea pig, and non-human primate (NHP) models. Elise returned to Emory in 2018 to begin her graduate studies in the Immunology and Molecular Pathogenesis PhD program and joined the Paiardini lab in 2019. In the Paiardini lab, Elise has led multiple in vivo studies in SIV/SHIV-infected and SARS-CoV-2-infected- rhesus macaques (RMs). The SIV/SHIV studies she led focused on 1) investigating the impact of CD4 mimetic BNM-III-170 on the SHIV reservoir, 2) characterizing the effects of CD4 binding-site bNAb monotherapy and combination therapy on a diverse latent pool at analytic treatment interruption (ATI) and 3) evaluating the ability of FTY720 + IL-15SA + aPD-1 to enhance viral control and lymphoid tissue CD8+ T cell antiviral function in SIV-infected RMs at ATI. The SARS-CoV-2 studies Elise helped lead focused on characterizing 1) the role of type I interferons in SARS-CoV-2 pathogenesis and 2) infiltrating myeloid populations that orchestrate lower airway inflammation in COVID-19.

In her free time, Elise enjoys running, frequenting donut shops in Atlanta, traveling, and spending time with friends, family, and her cat Joe.

Elise Viox, B.S., B.A.

PhD Candidate

Elise Viox, B.S., B.A.



  • PhD Immunology and Molecular Pathogenesis, Emory University (Atlanta GA), 2018-Current

  • B.S. Biology, B.A. Human Health, Emory University (Atlanta, GA), 2011-2015


  • Graduate Student, Dr. Paiardini Lab, Emory National Primate Research Center (Atlanta, GA), 2018 – present

  • Postbaccalaureate IRTA Fellow, Dr. Mascola Lab, NIH Vaccine Research Center (Bethesda, MD), 2016 – 2018

Selected Publications:

  • Upadhyay AA*, Viox EG*, Hoang TN*, Boddapati AK, Pino M, Lee MY, Corry J, Strongin Z, Cowan DA, Beagle EN, Horton TR, Hamilton S, Aoued H, Harper JL, Edwards CT, Nguyen K, Pellegrini KL, Tharp GK, Piantadosi A, Levit RD, Amara RR, Barratt-Boyes SM, Ribeiro SP, Sekaly RP, Vanderford TH, Schinazi RF, Paiardini M, Bosinger SE. TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques. Nat Commun. 2023 Apr 6;14(1):1914. doi: 10.1038/s41467-023-37425-9. PMID: 37024448; PMCID: PMC10078029.

  • Mallarino-Haeger C*, Pino M*, Viox EG, Pagliuzza A, King CT, Nguyen K, Harper JL, Aldrete SDM, Cervasi B, Delman KA, Lowe MC, Chomont N, Marconi VC, Paiardini M. HIV-1 DNA and Immune Activation Levels Differ for Long-Lived T-Cells in Lymph Nodes, Compared with Peripheral Blood, during Antiretroviral Therapy. J Virol. 2023 Mar 27:e0167022. doi: 10.1128/jvi.01670-22. Epub ahead of print. PMID: 36971588.

  • Pino M*, Pagliuzza A, Pampena MB, Deleage C, Viox EG, Nguyen K, Shim I, Zhang A, Harper JL, Samer S, King CT, Cervasi B, Gill KP, Ehnert S, Jean SM, Freeman ML, Lifson JD, Kulpa D, Betts MR, Chomont N, Lederman MM, Paiardini M. Limited impact of fingolimod treatment during the initial weeks of ART in SIV-infected rhesus macaques. Nat Commun. 2022 Aug 27;13(1):5055. doi: 10.1038/s41467-022-32698-y. PMID: 36030289; PMCID: PMC9420154.

  • Hoang TN*, Pino M*, Boddapati AK*, Viox EG, Starke CE, Upadhyay AA, Gumber S, Nekorchuk M, Busman-Sahay K, Strongin Z, Harper JL, Tharp GK, Pellegrini KL, Kirejczyk S, Zandi K, Tao S, Horton TR, Beagle EN, Mahar EA, Lee MYH, Cohen J, Jean SM, Wood JS, Connor-Stroud F, Stammen RL, Delmas OM, Wang S, Cooney KA, Sayegh MN, Wang L, Filev PD, Weiskopf D, Silvestri G, Waggoner J, Piantadosi A, Kasturi SP, Al-Shakhshir H, Ribeiro SP, Sekaly RP, Levit RD, Estes JD, Vanderford TH, Schinazi RF, Bosinger SE, Paiardini M. Baricitinib treatment resolves lower-airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques. Cell. 2021 Jan 21;184(2):460-475.e21. doi: 10.1016/j.cell.2020.11.007. Epub 2020 Nov 10. PMID: 33278358; PMCID: PMC7654323.

*These authors contributed equally

bottom of page